Transarterial Chemoembolization (TACE) plus Sorafenib Versus TACE for Intermediate or Advanced Stage Hepatocellular Carcinoma: A Meta-Analysis

Open Access

Peer-reviewed

Research Article

Leida Zhang,

Affiliation Department of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University, Chongqin, People’s Republic of China
⨯
Peng Hu,

Affiliation Department of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University, Chongqin, People’s Republic of China
⨯
Xi Chen,

Affiliation Department of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University, Chongqin, People’s Republic of China
⨯
Ping Bie

* E-mail: pengboyfei@msn.com

Affiliation Department of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University, Chongqin, People’s Republic of China
⨯

Reader Comments (0)

Hepatocellular carcinoma
Is the Subject Area "Hepatocellular carcinoma" applicable to this article?

Thanks for your feedback.
Metaanalysis
Is the Subject Area "Metaanalysis" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Adverse events
Is the Subject Area "Adverse events" applicable to this article?

Thanks for your feedback.
Randomized controlled trials
Is the Subject Area "Randomized controlled trials" applicable to this article?

Thanks for your feedback.
Database searching
Is the Subject Area "Database searching" applicable to this article?

Thanks for your feedback.
Adverse reactions
Is the Subject Area "Adverse reactions" applicable to this article?

Thanks for your feedback.
Publication ethics
Is the Subject Area "Publication ethics" applicable to this article?

Thanks for your feedback.